ITEM 1.01 Entry into a Material Definitive Agreement
On February 27, 2020, Boston Scientific Corporation (the "Company") entered into
a $1.000 billion credit agreement (the "2020 Credit Agreement") by and among the
Company, as Borrower, the several lenders party thereto, Wells Fargo Bank,
National Association, as Syndication Agent, The Bank of Nova Scotia and Wells
Fargo Securities, LLC, as Joint Lead Arrangers and Joint Bookrunners, and The
Bank of Nova Scotia, as Administrative Agent.
The 2020 Credit Agreement provides for a $1.000 billion 364 Day Term Loan (the
"2020 Term Loan"), maturing on February 25, 2021. The principal amount of the
2020 Term Loan will bear interest at an annual rate of LIBOR plus a margin of
0.65%. In addition, the Company will pay customary expenses.
The 2020 Credit Agreement contains covenants which, among other things, require
that the Company maintain a maximum leverage ratio of 3.75x; provided that for
the two consecutive fiscal quarters ended immediately following the consummation
of a "Qualified Acquisition" (the acquisition on August 19, 2019 of BTG plc, a
public company organized under the laws of England and Wales and any other
transaction for which the consideration exceeds $1.0 billion and for which the
Company notifies the Administrative Agent that such transaction is a Qualified
Acquisition under the 2020 Credit Agreement), the maximum leverage ratio shall
be 4.75x, and shall be decreased to 4.50x, 4.25x, 4.00x, for the next three
fiscal quarter-ends after such two fiscal quarter-ends, respectively, and then
to 3.75x for each fiscal quarter-end thereafter. The ratio is calculated based
on earnings before interest, taxes, depreciation and amortization, as adjusted
pursuant to the 2020 Credit Agreement. The 2020 Credit Agreement also contains
customary events of default, which may result in the acceleration of any
outstanding commitments.
The Company has customary corporate and commercial banking relationships with
the lenders, the Syndication Agent and the Administrative Agent and their
affiliates.
A copy of the 2020 Credit Agreement is attached hereto as Exhibit 10.1 and is
incorporated herein by reference. The foregoing description of the 2020 Credit
Agreement is qualified in its entirety by reference to the full text of the 2020
Credit Agreement.
ITEM 2.03 Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant
The information set forth under Item 1.01 is hereby incorporated by reference
into this Item 2.03.
ITEM 8.01 Other Events
The 2020 Term Loan will be used to repay the remaining amounts outstanding under
the three-year tranche ("Tranche 2 Loan") of the two tranche $2.000 billion Term
Loan Credit Agreement entered into on December 19, 2018 (the "2018 Credit
Agreement"), among the Company as borrower, the lenders from time to time party
thereto and Barclays Bank PLC as administrative agent and to pay transaction
costs in relation to such repayment and the 2020 Credit Agreement. The principal
amount of the Tranche 2 Loan under the 2018 Credit Agreement bore interest at an
annual rate based on LIBOR plus a margin of 1.125% for the duration of the
Tranche 2 Loan. For more information regarding the 2018 Credit Agreement, see
Items 1.01, 2.03 and 9.01 in the Company's Form 8-K filed with the
Securities and Exchange Commission ("SEC") on December 21, 2018, which includes
such agreement as Exhibit 10.3 and Item 2.03 in the Company's Form 8-K filed
with the SEC on August 19, 2019. Such descriptions are incorporated in this Item
8.01 by reference. In December 2019, the Company repaid remaining amounts
outstanding under the two-year tranche.
ITEM 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit Description
No.
10.1 Credit Agreement dated as of February 27, 2020, by and among Boston
Scientific Corporation, the several lenders parties thereto, Wells Fargo
Bank, National Association, as Syndication Agent, and The Bank of Nova
Scotia, as Administrative Agent.
104 Cover Page Interactive Data File - the cover page XBRL tags are embedded
within the Inline XBRL document
© Edgar Online, source Glimpses